Skip to main content
Figure 3 | BMC Cancer

Figure 3

From: Relevance of circulating nucleosomes and oncological biomarkers for predicting response to transarterial chemoembolization therapy in liver cancer patients

Figure 3

Receiver operating characteristic (ROC) curves indicating the profile of sensitivity and specificity for the estimation of non-response to therapy over the whole range of possible cutoffs for nucleosomes (24 h), alkaline phosphatase (AP 24 h) and the risk score of the combination of both markers and the number of TACE cycle that was identified as best predictive model in multivariate analysis.

Back to article page